Virtus ETF Advisers LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,877
-42.0%
19,835
-9.1%
0.04%
-40.6%
Q2 2023$108,411
+67.9%
21,813
+66.9%
0.06%
+77.8%
Q1 2023$64,571
-43.3%
13,071
-27.8%
0.04%
-39.0%
Q4 2022$113,830
-8.2%
18,097
+57.9%
0.06%
+20.4%
Q3 2022$124,000
-4.6%
11,462
+0.7%
0.05%
+2.1%
Q2 2022$130,000
+31.3%
11,383
+4.9%
0.05%
+9.1%
Q1 2022$99,000
-42.1%
10,848
-5.6%
0.04%
-32.3%
Q4 2021$171,000
-20.5%
11,487
+37.1%
0.06%
-31.6%
Q3 2021$215,000
-6.5%
8,379
-5.0%
0.10%0.0%
Q2 2021$230,000
-39.2%
8,817
-17.8%
0.10%
-40.6%
Q1 2021$378,000
+42.1%
10,721
+1.8%
0.16%
+45.5%
Q4 2020$266,000
-7.3%
10,536
+38.4%
0.11%
-27.2%
Q3 2020$287,000
-22.4%
7,611
-12.0%
0.15%
-13.7%
Q2 2020$370,000
+43.4%
8,650
-34.9%
0.18%
+65.1%
Q1 2020$258,000
-34.7%
13,279
-12.7%
0.11%
+63.1%
Q4 2019$395,000
+51.9%
15,214
+59.3%
0.06%
+25.0%
Q3 2019$260,000
-4.1%
9,552
-5.3%
0.05%
-8.8%
Q2 2019$271,00010,0840.06%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders